Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Experts predict consumers will pay nearly double the price per pound for certain types of turkey than the average cost just five years ago.
Russia has carried out missile attacks across cities in Ukraine, including its capital Kyiv.
Her songs reflected her pride in her rural Kentucky background and made her a Country Music Hall of Famer.
